Updates on Noninvasive Ventilation in COPD

Slides:

Advertisements

Similar presentations

Nebulization during spontaneous breathing, CPAP and Bilevel: a randomized analysis of pulmonary radioaerosol deposition RESPIRATORY CARE APRIL 2014 VOL.

Advertisements

Titration Guidelines for CPAP, APAP and BiLevel Therapy Know your patient Titrate Successfully Pamela Minkley RRT, RPSGT, CPFT Make Sleep a Priority.

Part I: Noninvasive Positive Pressure Ventilation in the Acute Care Facility By: Susan P. Pilbeam, MS, RRT, FAARC John D. Hiser, MEd, RRT, FAARC Ray Ritz,

นพ. ธรรมศักดิ์ ทวิช ศรี หน่วยเวชบำบัด วิกฤต ฝ่ายวิสัญญีวิทยา รพ. จุฬาลงกรณ์

NIV Why? How?. Non Invasive Ventilation – a guide to difficult choices Dr Sanj Fernando.

Indication and use of Domiciliary NIV

Applying the New Multiple Sclerosis Guidelines to Clinical Practice

Advanced Ventilation Research

Overview The Burden of COPD Main Challenges in the Diagnosis of COPD.

Assessing COPD in Primary Care

Diabetic Dyslipidemia in Practice

Duration of Dual Antiplatelet Therapy Post-ACS: Lessons From Clinical Trials.

Chronic Hepatitis C Virus Infection

Session 4: Living with and managing nocturnal hypoventilation in MND

Session 4: Living with and managing nocturnal hypoventilation in MND

Advances in Managing Inhibitors in Patients With Hemophilia A

Acute Heart Failure.

Monica M. Vasquez, MPH, Leslie A. McClure, PhD, Duane L

Hyperkalemia in the Hospital: Collaboration to Improve Transitions of Care.

Understanding Biologics

COPD Management.

The HCV Revolution: Are You and Your Practice Ready?

Insulin/GLP-1 Agonist Combinations

Seasonal Allergic Rhinitis

Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.

Dual Bronchodilation in COPD: From Clinical Trial Evidence to Clinical Practice.

Hot Topics in Hemophilia Nursing

Strategies for Assessing and Preserving Function in ALS

Natural History of Atherothrombosis Finding the Right Risk-Benefit Balance.

A Comprehensive Strategy Toward the Patient With Rhinorrhea

When Patients With Depression Have Cognitive Deficits

Do CNV Subtypes Matter for Prognosis, Diagnosis, and Treatment?

Tailoring Hemophilia Prophylaxis Therapy

Terms of Use. Terms of Use.

New Pathways in Lipid Care

Session 3: Living with and managing nocturnal hypoventilation in MND

Insulin/GLP-1 Agonist Combinations

Real-World Evidence in VTE

A Primer on Medication Delivery Systems in COPD Management

Immunotherapy for cSCC

Heart Failure Hospitalization Risks with DPP-IV Inhibitors: Myth or Reality?

Translating the Latest and Greatest Advances in PAH Into Clinical Practice.

Simplifying Insulin Delivery for Better Patient Outcomes in T2D

EARLY Combination Therapy in PAH: What Every Cardiologist Needs to Know.

Combining Efforts for Older Drivers: Licensing Agencies, Occupational Therapists, and Clinicians.

Key Questions for nAMD Treatment Success

Noninvasive Positive-Pressure Ventilation In COPD

Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.

A Primer on Medication Delivery Systems in COPD Management

Understanding the Updated Guidelines for ALK Testing in NSCLC

Are We Making Progress in the Management of Huntington Disease?

Insulin in Diabetes Management: Effective Patient Selection Is Key

Optimizing Treatment in HR-Positive Breast Cancer: A Case-Based Discussion.

Disease Burden of VTE Phases of VTE Treatment.

Diagnosing Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome

This program will include a discussion of off-label treatment or use of investigational agents not approved by the FDA for use in the US, and data that.

Transitioning Therapy in PAH: Practical Strategies and Considerations

Real-World Evidence.

Evaluating the Science of Cardiogenic Shock

Obesity hypoventilation syndrome (OHS) management strategy.

Patient and Clinician Perspectives on Preventive Therapy for Migraine

Evaluating the Totality of Evidence

Enthesitis in Psoriatic Arthritis: Disease, Diagnosis and Decisions

Exploring the Use of Adeno-Associated Virus for Gene Therapy

Kaplan-Meier curve for the probability of noninvasive ventilation (NIV) failure relative to continuous use of NIV and stratified for Acute Physiology and.

Characterizing Virological Suppression in Today's Treatment Paradigm

The Power of As-Treated Analyses

What's New in NOACs in AF?.

Total dynamic dead space (VD/VT) in bilevel versus pressure-support and pressure-assist noninvasive ventilation (NIV) face masks. └: Respironics BIPAP.

Presentation transcript:

Updates on Noninvasive Ventilation in COPD

Overview of COPD

Burden of COPD

Hypercapnia in Stable COPD

Role of NIV in Treating Acute COPD

Evidence for NIV for Acute COPD

History of NIV in Patients With Stable COPD

Rationale for Long-Term Use of NIV Effects on Patients With SDB

Rationale for Long-Term Use of NIV Effects on Patients With SDB (cont)

Use of Supplemental O2 in Severe Hypercapnia

Studies of Long-Term NIV in Patients With Stable COPD

NIV in Patients With Stable COPD

NIV in Patients With Stable COPD (cont)

Key Points Regarding the RCTs

HOT-HMV Trial

HOT-HMV Trial: Outcome and Results

Evaluating Patients With Stable COPD for Use of Long-Term NIV

Evaluating Patients With Stable COPD for Use of Long-Term NIV (cont)

Type of Ventilator in COPD: CPAP vs BiPAP?

Practical Considerations for Home Use of NIV

Importance of Proper Device Selection

Introducing the Mask Approach to Practical Use by the Patient

Concluding Remarks